Aandelen in “Biotechnologie”

Aandeel Datum Koers Evolutie
vlag Ultragenyx Pharmaceutical Inc. 15/05 25,000 USD
-3,10% 		-3,10%
vlag uniQure N.V. 15/05 27,050 USD
-2,52% 		-2,52%
vlag UroGen Pharma Ltd 15/05 28,780 USD
-3,03% 		-3,03%

Nieuws over “Biotechnologie”

01:02 · Biogen Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Biogen Inc. (BIIB) · Persbericht

01:02 · Biogen Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Biogen Inc. (BIIB) · Persbericht

15/05 · Pulmatrix Announces First Quarter 2026 Financial Results · Persbericht

15/05 · Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers - ATRA · Persbericht

14/05 · Atrium Therapeutics Reports First Quarter 2026 Financial Results · Persbericht

14/05 · Inhibrx Reports First Quarter 2026 Financial Results · Persbericht

14/05 · Co-Diagnostics Reports First Quarter 2026 Financial Results · Persbericht

14/05 · ALDX INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026 · Persbericht

14/05 · ATRA INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026 · Persbericht

14/05 · Cisco Systems kent grootste koersstijging sinds 2011 · Tijd.be (€)

De Amerikaanse beurzen kleuren groen, met extra steun van zwaargewicht Nvidia. Cisco Systems kent een koersexplosie, terwijl het Belgische MDxHealth halveert.

14/05 · IMMP INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 · Persbericht

14/05 · Rigel to Present at the 2026 RBC Capital Markets Global Healthcare Conference · Persbericht

14/05 · Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment · Persbericht

14/05 · REGENXBIO Reports First Quarter 2026 Financial Results and Operational Highlights · Persbericht

14/05 · REGENXBIO Announces Positive Topline Results from Pivotal Phase III AFFINITY DUCHENNE® Study of RGX-202 · Persbericht

14/05 · BrewDog Shakes Up RTD Shelves Across the UK with New Nostalgia-Led Wonderland Cocktails · Persbericht

14/05 · Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab · Persbericht

14/05 · Topline Results from Phase 2 CELIA Study of Diranersen (BIIB080): First Study to Show Reduction in Tau Pathology and Cognitive Benefit in Patients with Early Alzheimer’s Disease · Persbericht

13/05 · Combined General Meeting of June 3, 2026 · Persbericht

13/05 · Precigen Reports First Quarter 2026 Financial Results and Business Updates · Persbericht

13/05 · Beam Therapeutics Supports AlphaDetect to Accelerate Detection of Alpha-1 · Persbericht

Mijn selecties